Thematic

Obesity & GLP-1 ETFs

Concentrated bets on a small number of drugmakers plus the supply chain around them. Because two companies dominate the drug class, most funds end up looking similar with different wrappers.

Theme performance

Equal-weighted across every fund in this objective

1Y: +11.4%
5Y ann.: —
10Y ann.: —
All-time ann.: —

Sort3 funds

OZEM

Roundhill GLP-1 & Weight Loss ETF

Roundhill

Concentrated exposure to GLP-1 drugmakers and the manufacturers supplying them.

Fee: 0.59%
AUM: $100M
Yield: 0.8%

1Y: +12.6%
5Y ann.: —
10Y ann.: —
Max ann.: —

THNR

Amplify Weight Loss Drug & Treatment ETF

Amplify

Broader metabolic health basket including devices, diagnostics and bariatric care.

Fee: 0.59%
AUM: $50M
Yield: 0.6%

1Y: +10.4%
5Y ann.: —
10Y ann.: —
Max ann.: —

SLIM

Tema Cardiovascular and Metabolic ETF

Tema

Cardiometabolic health more broadly: obesity, diabetes and heart disease treatment.

Fee: 0.75%
AUM: $30M
Yield: 0.7%

1Y: +11.1%
5Y ann.: —
10Y ann.: —
Max ann.: —